Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants

Clinical trial NCT04657211 · COMPLETED

Trial details

NCT number: NCT04657211
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2021-01-14
Primary completion: 2024-07-01
Enrollment: 1212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.